Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

NCT02979873 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

NIH

Sponsor class

Conditions

Severe Aplastic Anemia

Interventions

DRUG: Sirolimus

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)